Point72 Middle East FZE’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,100
Closed -$3M 586
2023
Q4
$3M Sell
11,100
-2,400
-18% -$593K 0.09% 301
2023
Q3
$3.32M Buy
13,500
+11,400
+543% +$3.12M 0.11% 234
2023
Q2
$637K Sell
2,100
-3,500
-63% -$973K 0.02% 712
2023
Q1
$1.48M Buy
+5,600
New +$1.42M 0.05% 398

Other funds holding HCA

Point72 Middle East FZE's HCA Position: Q4 2023 in Review

Point72 Middle East FZE sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 64,685 shares — an estimated $16M sold.

Point72 Middle East FZE first reported a position in HCA in Q4 2022 and held it in 2 quarters. The position peaked at $15.9M in Q3 2023. 1,057 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Point72 Middle East FZE reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 64,685 HCA Healthcare shares in Q4 2023, an estimated $16M.
  • Point72 Middle East FZE first reported a position in HCA Healthcare in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's HCA Healthcare position peaked at $15.9M in Q3 2023.
  • 1,057 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.